Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
biotech
bluebird bio
boston
boston blog main
boston top stories
clinical trials
column
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
gene therapy
health
joshua brumm
kaleido biosciences
life sciences
muscular dystrophy
myotonic dystrophy type 1
national blog main
national top stories
new york blog main
rare disease drugs
romesh subramanian
san diego blog main
san francisco blog main
susanna high
tc
vertex pharmaceuticals
wearables
What
data
2
×
diseases
2
×
genetic
2
×
ability
ago
biotechs
brought
challenges
choices
chronic
community
considering
disease
drug
dyne
early
environmental
expected
experimental
eyes
factors
gather
grail
having
health
healthcare
heavily
holy
humans
influenced
information
innovation
ipo
ipos
lifestyle
long
medicine
medicines
meeting
mobile
Language
unset
Current search:
genetic
×
diseases
×
data
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@techcrunch.com
9 years ago
Meeting The Challenges In Mobile Health Innovation
